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Abstract 
Many chemotherapeutic drugs have had success in treating a variety of 
cancers, but some can be harmful and cause adverse side affects such as hair loss 
and nausea. Cisplatin is a well-known chemotherapy drug that has been used to 
treat a countless number of different types of cancers including non-small cell lung 
cancers (NSCLC). Because of its nonspecificity and secondary effects, investigation 
into alternative non-small cell lung cancer targeting drugs is necessary. The recently 
synthesized bis-cation imidazolium salt system has displayed antiproliferative 
activity, but its mechanism of action remains undetermined. The system explores 
the use of two napthalenes, two imidazole salts, and linking carbon chains varying 
from 1-12 carbons in length. Here, the system was tested for possible DNA 
intercalation using fluorescent intercalator displacement (FID) and viscosity 
experimentation. Results from FID exhibit negligible displacement activity of ethidium 
bromide from the 4 selected compounds. In contrast, viscosity results demonstrate 3 of 4 
compounds showing greater DNA interaction compared to the acridine orange control. 
These opposing conclusions ultimately determine DNA interaction is present, but not 
strong enough to effectively displace a known intercalator. Overall, results do not 
concretely reveal a mechanism of DNA interaction.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Of the 224,390 predicted new cases of lung cancer in 2016 over 83% will be non-
small cell lung cancers (NSCLC).1 Treatments for lung cancer vary from surgery, 
radiation, to chemotherapy and the method and drug chosen for treatment are specifically 
tailored to each patient. Cisplatin proves to be very effective and widely used as a 
chemotherapy drug, but it is known to cause harmful side effects to non-cancer cells.2 
Improving upon current cancer-targeting drugs leaves the possibility for the development 
of more effective and safer compounds to use for the treatment of NSCLC.  
Distinguished professor Dr. Wiley Youngs’ research group works with 
imidazolium salts as a means to better treat NSCLC. By varying the ligand additions to 
the various positions of the imidazole ring, the Youngs lab has developed numerous anti-
cancer compounds, of which methyl naphthalene on the nitrogen atoms of the imidazole 
give the best activity. While these compounds exhibit antiproliferative activity, success 
has been limited due to poor solubility.3 Synthesized imidazole compounds thus far must 
first be dissolved into either dimethyl sulfoxide (DMSO) or cyclodextrin before testing.  
Echinomycin and ethidium bromide are known compounds with planar aromatic 
structure that allow for DNA intercalation. Echinomycin specifically exhibits double 
intercalation behavior.4 This double intercalation is of interest for the bis-imidazolium 
salt compounds as a possible mechanism of drug targeting. Recently, the Youngs lab has 
taken interest in synthesizing a bis-cation system, which consists of two napthalenes, two 
imidazole salts, and a linking chain between them that varies in length from 1-12 carbons. 
This bis-cation system produces more polar compounds, increasing the chances of 
aqueous solubility.  
 Figure 1. Displays the general structure of the bis-cation system, where n is the varying 
number of carbon atoms connecting the two chains and the R groups in the 4, 5 positions 
of the imidazole salts are defined as hydrogen.  
 
Because the bis-cations have shown increased polarity and solubility, the purpose 
of this project is to test the potential intercalation of the system by means of viscosity and 
fluorescent intercalator displacement (FID) to determine any intercalation with DNA. 
Analyzing viscosity, it is hoped that these compounds increase the viscosity of the DNA, 
meaning the backbone has been slightly unwound to ease the strain caused by the 
intercalating compound.5 FID experiments using ethidium bromide will aid in 
demonstrating the possible intercalation properties of the bis-cations. It is hoped that a 
decrease in fluorescence will be seen, implying the displacement of the ethidium bromide 
by the compound.6 If this analysis proves useful in better understanding the mechanism 
of the bis-cation compounds, new compounds can be synthesized specific to the binding 
mechanism.  
Methods 
 
The bis-cation system was tested for intercalating behavior by both viscosity and 
fluorescent intercalator displacement (FID). The system contained linker compounds 
ranging from 1-12 carbons in length. For time convenience, 4 of the 12 compounds were 
chosen for experimentation: methyl, propyl, pentyl, and heptyl. All compounds were first 
solubilized in DMSO (10%) and diluted to 1mL with Invitrogen™ Ultra Pure Distilled 
Water (DNAse, RNAse free).  
Invitrogen™ calf thymus DNA 10 mg/mL; Thermo Fisher Scientific stock 
solutions were separately prepared for each testing method. For a concentration between 
115 μM and 135 μM for FID, 30 mL of Tris/NaCl (5mM/50mM) buffer and 110 μL of 
calf thymus DNA were added to a falcon tube and vortexed. For a concentration between 
225 μM and 250 μM for viscosity, 70mL of Tris/NaCl (5mM/50mM) buffer and 560 μL 
of calf thymus DNA were added to a falcon tube and vortexed. An Agilent Varian Cary® 
100 Bio UV-Visible Spectrophotometer was used to determine the concentrations of the 
prepared DNA solutions. The instrument was warmed up for 20-30 minutes. The 
software was opened and the instrument was zeroed. Tris/NaCl (5mM/50mM) buffer was 
added to the blank cuvette and placed in the back of instrument as the reference. DNA 
solution was added to the sample cuvette and placed in the front of the instrument. After 
absorbance values were collected between 200 nm and 800 nm, x and y peaks were 
labeled on the graph and the DNA absorbance value was recorded at 258 nm. The Beer-
Lambert equation was utilized to calculate the concentration of the DNA solution using 
the recorded absorbance and extinction coefficient (6600 M-1 cm-1).7 
Fluorescent intercalator displacement was conducted based on the procedure 
previously described by Boger et al. (2001). A HORIBA Jobin Yvon Fluoromax-4 
Spectrofluorometer was used to conduct FID testing. The Fluoromax-4 was warmed up 
for at least 30 minutes. With no cuvette in the instrument, a lamp excitation spectrum was 
collected to determine the initial intensity. Nanopure water (3 mL) was added to the 
cuvette and an emission spectrum was collected. Both lamp and water spectra were 
collected using default parameters. Nanopure water was discarded and a 120 μM DNA 
solution (2.997 mL) and 3 μL of ethidium bromide were added to the cuvette. The 
excitation wavelength was set at 510 nm and the emission wavelength range was set 
between 465 nm and 750 nm. An initial emission spectrum was collected before any 
compound was titrated. Compound was then titrated in from 0-30 μL by 2 μL additions, 
30-100 μL by 10 μL additions, and 100-600 μL by 100 μL additions, and all emission 
spectra were recorded. A pipette was used to thoroughly mix each addition and the 
solution was given 2 minutes between each reading to equilibrate. Intensity values were 
normalized against the blank to account for the lamp intensity decreasing with each use. 
Normalized intensities were graphed against concentration of the solution. 
Viscosity testing was based on the procedure carried out by Xia-Bing Fu et al. 
(2014). A viscometer and thermometer were placed into a water bath. The water bath sat 
atop a VWR heating/stirring plate and was kept between 29°C and 30°C throughout 
testing. Tris/NaCl buffer (8 mL) was placed into the large bulb of the viscometer. A bulb 
was used to entirely coat the large and small arms of the viscometer. Timing began as the 
solution crossed the line above the small bulb and ended where the solution crossed the 
line below the small bulb. Flow times were recorded in triplicate. The buffer was 
discarded and a 250 μM DNA solution (8mL) was added to the viscometer and flow 
times were recorded in triplicate. To the DNA, 7 separate 8 μL additions of the select bis-
imidazoium cation were titrated into the solution. The bulb was used to draw solution 
into the small arm to collect the addition, the initial flow through was not recorded, and 
air was bubbled through the viscometer from the small arm to ensure complete mixing 
before any readings of the additions were taken. All 8 μL additions flow times were 
recorded in triplicate. Triplicate trials of the buffer, DNA, and DNA and additions were 
averaged and normalized against the buffer.  
It should be noted that extreme sensitivity associated with this technique renders 
viscosity data highly variable and sometimes inaccurate. Multiple factors influence the 
flow time: recording entry and exit into the small bulb, temperature, and thorough mixing 
of additions into solution.  
Results and Discussion 
Fluorescent intercalator displacement provides insight into the affinity for DNA 
of the bis-cation compounds. This technique measures changes in fluorescence intensity 
of a solution. When ethidium bromide intercalates between DNA base pairs, fluorescence 
significantly increases. Utilizing this fluorescent compound, the degree to which the 
titrated compound displaces ethidium bromide and binds to DNA can be determined. As 
ethidium bromide is displaced by the compound, fluorescence should decrease.8 FID 
experimentation was conducted on netropsin for means of comparison to the compounds. 
Netropsin is a known groove binder that has the ability to displace ethidium bromide.8 To 
ensure neither the DMSO nor water resulted in a decrease in fluorescence intensity, a 
10% DMSO in water solution was used as a vehicle control.  
 
Figure 2. Figure 2 displays the graph of normalized intensities vs. the concentration of 
compound of the vehicle control, netropsin, and the four compounds.  
 
 All compounds show some degree of ethidium bromide displacement; however, 
the observed displacement is not significant as compared to the netropsin shown by the 
red line. No bis-cation compound comes close to rate of decreasing fluorescence intensity 
in comparison to netropsin. This pattern continues into the 30-100 μL and 100-600 μL 
additions. The orange line from the graph represents the heptyl compound and proves 
most effective in ethidium bromide displacement of all four compounds. Overall, the 
compounds did not display a stronger affinity for DNA due to their lack of displacement 
of the ethidium bromide. 
Viscosity testing was also used to determine any intercalating behavior of 
compounds. DNA intercalation causes an increase in flow time. Compound intercalation 
causes unwinding of the DNA backbone in order to reduce strain. This base pair 
separation lengthens the DNA and increases viscosity.9 Acridine orange and a 10% 
DMSO in water solution were used as a known comparison and vehicle control 
respectively.  
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Figure 3. Figure 3 displays the graph of normalized viscosities vs. the concentration of 
compound by titration divided by the concentration of the DNA stock solution of the 
vehicle control, acridine orange, and the four compounds.  
 
Contrary to FID, three of the four compounds displayed slower flow rates 
compared to the acridine orange control. These increases in viscosity suggest that the 
propyl, pentyl, and heptyl compounds exhibit DNA interactions to a higher degree than 
the control.  
Interestingly, the methyl compound experienced solubility issues. Using twice the 
mass compared to FID, the 10% DMSO in water solution proved insufficient to 
completely solubilize the compound. Poor solubility of the compound may decrease its 
actual intercalating potential. No other compounds experienced these issues.  
While FID testing concluded insignificant displacement of ethidium bromide, 
viscosity testing showed three of the four compounds possessing increased viscosities 
compared to the control. This contradicting data indicates interaction between the 
compound and DNA may be present, but is not strong enough to effectively displace a 
known intercalator such as ethidium bromide. Results from this experiment cannot 
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provide a concrete mechanism of DNA interaction of the compounds. Future research 
will likely investigate other mechanisms of action of the bis-cation species. 
Conclusion 
 The recently synthesized bis-cation system exhibits more polar imidazolium salts, 
causing increased solubility. The purpose of this project was to test for possible 
intercalation of DNA. Experimentation was conducted by both FID and viscosity 
measures. The compounds displayed insignificant displacement of ethidium bromide 
compared to the Netropsin control. The heptyl compound exhibited the greatest 
intercalation of the compounds, but compared to the control its activity was negligible. 
Viscosity testing concluded the propyl, pentyl, and heptyl compounds showed increased 
viscosity times compared to the acridine orange control. Overall, the compounds 
exhibited some interaction with the DNA, but this interaction was not strong enough to 
displace a known intercalator.  
 Solubility remains the issue at large. The larger linker compounds exhibit 
increased degrees of intercalation, but their size causes solubility issues in the 10% 
DMSO in water solutions. A possible solution to avoid sacrificing intercalation for 
solubility is to test other solvents apart from DMSO and water for solubilizing 
compounds. Cyclodextrin may prove a viable option for compound solubility issues 
because of its ability to bind the compound into its lipophilic pocket.  
 From this experiment, it was determined that the bis-cation system causes a small 
degree of DNA intercalation, which proves to be too insignificant for a valid mechanism 
of action. In future research, it is likely the lab will test for alternative mechanisms of 
action rather than continuing to experiment with DNA interactions.  
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Safety Appendix 
Common precautions were taken the entire duration of this research. Gloves, 
goggles, proper shoes, working in the hoods, and an optional lab coat were used at all 
times during experimentation. Undergraduate students were aware of fire extinguisher 
and eye wash station locations.  
Special attention was paid when handling and disposing of netropsin, ethidium 
bromide, acridine orange, DMSO, and calf thymus DNA. In this case, netropsin was 
mixed with ethidium bromide from FID experimentation. The combination of netropsin, 
ethidium bromide, and calf thymus DNA were discarded in a liquids waste container 
specifically for ethidium bromide titrated with imidazolium salt compounds. All tips, 
Kimwipes, and gloves that came into contact with ethidium bromide were disposed of in 
a designated solids waste container. Undergraduate students never pipetted from the 
ethidium bromide stock solution. From viscosity testing, acridine orange, imidazolium 
salt compounds, and calf thymus DNA solutions were discarded in the proper liquids 
waste container that did not contain ethidium bromide. Tips that came into contact with 
acridine orange, imidazolium salt compounds, and calf thymus DNA were discarded in a 
specific solids waste container.  
The full properties of the imidazolium salts were unknown. Preventative measures 
including limited exposure, gloves, and goggles were carried out in times of working 
with those compounds. DMSO (10%) in water and compound solutions were discarded in 
a specific liquids waste container. Because it is generally regarded as safe (GRAS), 
cyclodextrin may prove a viable option for safely solubilizing compounds compared to 
DMSO. 
 
